{"mainPropery":{"diseaseId":536,"diseaseName":"Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) ","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/536/acute-myeloid-leukemia-with-abnormal-bone-marrow-eosinophils-inv16p13q22-or-t1616p13q22","synonyms":["AML with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)","AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)","CBFB-MYH11","Acute myelomonocytic leukemia "],"synonyms-with-source":[{"name":"AML with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)","source":"Orphanet"},{"name":"AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)","source":"UpToDate"},{"name":"CBFB-MYH11","source":"Orphanet"},{"name":"Acute myelomonocytic leukemia ","source":"UpToDate"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"98829"},{"identifierType":"UMLS","identifierId":"C0023479"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%28%22Leukemia%2C%20Myelomonocytic%2C%20Acute/drug%20therapy%22%5BMesh%5D%20OR%20%22Leukemia%2C%20Myelomonocytic%2C%20Acute/epidemiology%22%5BMesh%5D%20OR%20%22Leukemia%2C%20Myelomonocytic%2C%20Acute/mortality%22%5BMesh%5D%20OR%20%22Leukemia%2C%20Myelomonocytic%2C%20Acute/therapy%22%5BMesh%5D%29%20AND%20Myelomonocytic%5Bti%5D%20AND%20%28%22humans%22%5BMeSH%20Terms%5D%20AND%20%222001/11/07%22%5BPDat%5D%20%3A%20%222011/11/04%22%5BPDat%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) . Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Acute+myelomonocytic+leukemia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) . Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98829' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6745,"questionText":"What is acute myelomonocytic leukemia?","answerText":"<strong>Acute myelomonocytic leukemia</strong> (AMML) is a cancer that typically develops in the <a href=\"http://cancer.gov/dictionary?CdrID=45622\" target=_blank>bone marrow</a> and <a href=\"http://cancer.gov/dictionary?CdrID=270735\" target=_blank>blood</a>&nbsp;of older individuals.&nbsp;&nbsp;AMML is one type of <a href=\"http://cancer.gov/dictionary?CdrID=46347\" target=_blank>acute myeloid leukemia</a>, a group of blood cancers that occur when the amount of <a href=\"http://cancer.gov/dictionary?CdrID=45993\" target=_blank>white blood cells</a>&nbsp;increases rapidly.&nbsp; Symptoms of AMML often include fatigue (due to <a href=\"http://cancer.gov/dictionary?CdrID=45360\" target=_blank>anemia</a>) or easy bruising or bleeding (due to <a href=\"http://cancer.gov/dictionary?CdrID=45365\" target=_blank>thrombocytopenia</a>).&nbsp; The cause of AMML is currently unknown.&nbsp; Treatment typically consists of <a href=\"http://cancer.gov/dictionary?CdrID=45214\" target=_blank>chemotherapy</a>.[5838]","dateModified":"2013-02-12T22:11:00"},"basicQuestions":[{"questionId":6746,"questionText":"How might acute myelomonocytic leukemia be&nbsp;treated?","answerText":"Acute myelomonocytic leukemia (AMML) is typically treated with <a href=\"http://cancer.gov/dictionary?CdrID=45214\" target=_blank>chemotherapy</a>, drugs injected into the bloodstream that target and destroy cancer cells.&nbsp; The amount and type&nbsp;of chemotherapy used to treat AMML depends on the age and health of the affected individual.&nbsp; The first step of chemotherapy for AMML is <a href=\"http://cancer.gov/dictionary?CdrID=45736\" target=_blank>induction therapy</a>, treatment with drugs that aim to destroy the cancer cells in the bone marrow and blood.&nbsp; Induction thearpy is followed by a rest phase to allow the affected individual to recover from the initial treatments.&nbsp; Then, the second step of chemotherapy is given, called <a href=\"http://cancer.gov/dictionary?CdrID=45654\" target=_blank>consolidation therapy</a>, which should destroy any cancer cells that may remain in the body.[5838]&nbsp; <a href=\"http://cancer.gov/dictionary?CdrID=46695\" target=_blank>Stem cell transplant</a> or participation in a <a href=\"http://cancer.gov/dictionary?CdrID=45961\" target=_blank>clinical trial</a> may also be used to treat AMML if chemotherapy treatments are unsuccessful.[5839]","dateModified":"2013-02-12T22:18:00","resourceClassificationName":"Treatment","references":[{"referenceId":5838,"authors":"American Cancer Society","articleTitle":"Detailed Guide","bookWebsiteJournalTitle":"Leukemia - Acute Myeloid (Myelogenous)","date":"January 2013","url":"http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/index","dateAccessed":"2013-02-12T00:00:00"},{"referenceId":5839,"authors":"National Comprehensive Cancer Network","articleTitle":"Acute Myeloid Leukemia","bookWebsiteJournalTitle":"NCCN Clinical Practice Guidelines in Oncology","date":"2013","url":"http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12758,"relatedDiseaseName":"Acute myeloid leukemia with recurrent genetic anomaly","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":38106,"abbreviatedInquiry":"What is acute myelomonocytic leukemia and how is it best treated?&nbsp; Is there any research or new treatment currently in trials that is available to treat this disease?&nbsp; My father has just been diagnosed with this condition.","caseQuestions":[{"questionId":6745,"questionText":"What is acute myelomonocytic leukemia?","answerText":"<strong>Acute myelomonocytic leukemia</strong> (AMML) is a cancer that typically develops in the <a href=\"http://cancer.gov/dictionary?CdrID=45622\" target=_blank>bone marrow</a> and <a href=\"http://cancer.gov/dictionary?CdrID=270735\" target=_blank>blood</a>&nbsp;of older individuals.&nbsp;&nbsp;AMML is one type of <a href=\"http://cancer.gov/dictionary?CdrID=46347\" target=_blank>acute myeloid leukemia</a>, a group of blood cancers that occur when the amount of <a href=\"http://cancer.gov/dictionary?CdrID=45993\" target=_blank>white blood cells</a>&nbsp;increases rapidly.&nbsp; Symptoms of AMML often include fatigue (due to <a href=\"http://cancer.gov/dictionary?CdrID=45360\" target=_blank>anemia</a>) or easy bruising or bleeding (due to <a href=\"http://cancer.gov/dictionary?CdrID=45365\" target=_blank>thrombocytopenia</a>).&nbsp; The cause of AMML is currently unknown.&nbsp; Treatment typically consists of <a href=\"http://cancer.gov/dictionary?CdrID=45214\" target=_blank>chemotherapy</a>.[5838]","dateModified":"2013-02-12T22:11:00","references":[{"referenceId":5838,"authors":"American Cancer Society","articleTitle":"Detailed Guide","bookWebsiteJournalTitle":"Leukemia - Acute Myeloid (Myelogenous)","date":"January 2013","url":"http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/index","dateAccessed":"2013-02-12T00:00:00"}]},{"questionId":6746,"questionText":"How might acute myelomonocytic leukemia be&nbsp;treated?","answerText":"Acute myelomonocytic leukemia (AMML) is typically treated with <a href=\"http://cancer.gov/dictionary?CdrID=45214\" target=_blank>chemotherapy</a>, drugs injected into the bloodstream that target and destroy cancer cells.&nbsp; The amount and type&nbsp;of chemotherapy used to treat AMML depends on the age and health of the affected individual.&nbsp; The first step of chemotherapy for AMML is <a href=\"http://cancer.gov/dictionary?CdrID=45736\" target=_blank>induction therapy</a>, treatment with drugs that aim to destroy the cancer cells in the bone marrow and blood.&nbsp; Induction thearpy is followed by a rest phase to allow the affected individual to recover from the initial treatments.&nbsp; Then, the second step of chemotherapy is given, called <a href=\"http://cancer.gov/dictionary?CdrID=45654\" target=_blank>consolidation therapy</a>, which should destroy any cancer cells that may remain in the body.[5838]&nbsp; <a href=\"http://cancer.gov/dictionary?CdrID=46695\" target=_blank>Stem cell transplant</a> or participation in a <a href=\"http://cancer.gov/dictionary?CdrID=45961\" target=_blank>clinical trial</a> may also be used to treat AMML if chemotherapy treatments are unsuccessful.[5839]","dateModified":"2013-02-12T22:18:00","resourceClassificationName":"Treatment","references":[{"referenceId":5838,"authors":"American Cancer Society","articleTitle":"Detailed Guide","bookWebsiteJournalTitle":"Leukemia - Acute Myeloid (Myelogenous)","date":"January 2013","url":"http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/index","dateAccessed":"2013-02-12T00:00:00"},{"referenceId":5839,"authors":"National Comprehensive Cancer Network","articleTitle":"Acute Myeloid Leukemia","bookWebsiteJournalTitle":"NCCN Clinical Practice Guidelines in Oncology","date":"2013","url":"http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf"}]},{"questionId":6747,"questionText":"Are there any clinical trials for acute myelomonocytic leukemia?","answerText":"<p>The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies. Currently,&nbsp;120 clinical trials are identified as enrolling individuals with acute myelomonocytic leukemia.&nbsp; To find these trials, click on the following link:&nbsp;<a href=\"http://www.clinicaltrials.gov/ct2/results?term=acute+myelomonocytic+leukemia&amp;recr=Open\" target=_blank>open studies for acute myelomonocytic leukemia</a>. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study’s contact information to learn more. Check this site often for regular updates.</p>\r\n<p>You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling <strong>1-800-411-1222</strong> to speak with a specialist, who can help you determine if you are eligible for any clinical trials. <br></font><span style=\"FONT-FAMILY: 'Courier New'; FONT-SIZE: 10pt\"></span>Patient Recruitment and Public Liaison Office<br>NIH Clinical Center<br>Bethesda, Maryland 20892-2655<br>Toll-free: 1-800-411-1222<br>Fax: 301-480-9793<br>E-mail: </font><a href=\"mailto:prpl@mail.cc.nih.gov\">prpl@mail.cc.nih.gov</font></a><br>Web site:&nbsp; </font><a href=\"http://clinicalcenter.nih.gov/\">http://clinicalcenter.nih.gov/</font></a></p>\r\n<p>If you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials at the <a href=\"http://clinicaltrials.gov/ct2/info/understand\">ClinicalTrials.gov Web page</a>.&nbsp; Resources on many charitable or special-fare flights to research and treatment sites and low-cost hospitality accommodations for outpatients and family members, as well as ambulance services, are listed on the Web site of the <a href=\"http://rarediseases.info.nih.gov/Resources.aspx?PageID=8\">Office of Rare Diseases Research (ORDR)</a>, part of the National Institutes of Health.</p>","dateModified":"2013-02-12T22:21:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Acute_myeloid_leukemia_with_abnormal_bone_marrow_eosinophils_inv(16)(p13q22)_or_t(16;16)(p13;q22)_"}